Good summary Inkling. We always need to read a different view to gain perspective that’s for sure. The science seems good as always but my concern is the lack of interest by a HNW individual or something akin to that. If the opportunity is this good it shouldn’t be a very hard sell? The science will be the science & the announcements will trickle through in regards to this. My preference for the next announcement is smart money coming in.
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?, page-159
-
- There are more pages in this discussion • 233 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.43 |
Change
0.025(1.78%) |
Mkt cap ! $243.6M | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.46 | $1.41 | $106.3K | 74.77K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3388 | $1.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.43 | 4882 | 1 |
View Market Depth
| Last trade - 16.10pm 07/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |